Abdulkerim Kolkiran

Dr. Abdulkerim Kolkiran


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2025 in Clinical Genetics
Verified
Journal Article
Closed access
AKAhmet KABLAN
Ahmet KABLAN
ASAbdullah Sezer
Abdullah Sezer
ABABDULLATİF BAKIR
ABDULLATİF BAKIR
ETElifcan Taşdelen
Elifcan Taşdelen
FBFirdevs Dinçsoy Bir
Firdevs Dinçsoy Bir
HGHakan Güneş
Hakan Güneş

16 January 2024 in Molecular Syndromology
Verified
Journal Article
Open access
PDF file
AKAbdulkerim Kolkiran
Abdulkerim Kolkiran
PŞPelin Özlem Şimşek-Kiper
Pelin Özlem Şimşek-Kiper
GYGöknur Topaloğlu Yasan
Göknur Topaloğlu Yasan
BKBeren Karaosmanoğlu
Beren Karaosmanoğlu
ETEkim Taşkıran
Ekim Taşkıran
KBKoray Boduroğlu
Koray Boduroğlu
Introduction: Gorlin syndrome is a rare, autosomal dominant multi-systemic disorder with a predisposition to the development of cancers such as medulloblastoma and nevoid basal cell carcinoma. Heterozygous pathogenic variants in PTCH1 are responsible for 90% of Gorlin syndrome cases. Pathogenic variants in PTCH1 cause overstimulation of the sonic hedgehog signaling pathway, which plays a role in the development of embryonic structures and tumorigenesis. Clinical major and minor diagnostic criteria for Gorlin syndrome have been determined. Odontogenic keratocyst (OKC) is the most common reason for medical admission in Gorlin syndrome. In this article, it is aimed to draw attention to the fact that patients with Gorlin syndrome are not very rare in our country and the variability in phenotypic and dysmorphic findings may be a clue for the diagnosis. Methods: Exome sequencing was performed on the Illumina NextSeq550 System platform by using the Ion Ampliseq exome RDY kit for Illumina. Sanger sequencing was performed accordingly for the other affected individuals in both families. Results: In this study, the clinical and molecular findings of 9 Gorlin syndrome patients from three unrelated families are presented. Macrocephaly, calcification of falx cerebri, palmar-plantar pits, rib anomalies, and OKC were detected in decreasing order in more than half of the patients. A novel heterozygous frameshift PTCH1 variant in family 1, a nonsense previously reported PTCH1 variant in family 2, and a novel heterozygous splice-site PTCH1 variant in family 3 were detected. Conclusion: Gorlin syndrome should be kept in mind in patients presenting with macrocephaly, palmoplantar pits, and OKC history. Careful examination of all family members is essential in the timely diagnosis of other affected individuals with minor phenotypic findings.

1 July 2021 in European Journal of Medical Genetics
Verified
Journal Article
Closed access
AKAbdulkerim Kolkiran
Abdulkerim Kolkiran
GÜGizem Ürel-Demir
Gizem Ürel-Demir
PŞPelin Özlem Şimşek-Kiper
Pelin Özlem Şimşek-Kiper
GUGülen Eda Utine
Gülen Eda Utine

8 March 2026 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
AKAbdulkerim Kolkiran
Abdulkerim Kolkiran
MKM Ataseven Kulalı
M Ataseven Kulalı
TDTuğba Daşar
Tuğba Daşar
AKAhmet KABLAN
Ahmet KABLAN
ETElifcan Taşdelen
Elifcan Taşdelen
ŞEŞenay Savaş Erdeve
Şenay Savaş Erdeve

13 June 2026 in Molecular Syndromology
Verified
Journal Article
Closed access
AKAbdulkerim Kolkiran
Abdulkerim Kolkiran
FBFirdevs Dinçsoy Bir
Firdevs Dinçsoy Bir
MKM Ataseven Kulalı
M Ataseven Kulalı
HÇHasibe Gökçe Çınar
Hasibe Gökçe Çınar
GYGöknur Topaloğlu Yasan
Göknur Topaloğlu Yasan
EAErgin Atasoy
Ergin Atasoy
Introduction/Background: Neurofibromatosis type 1 (NF1) and Auriculocondylar Syndrome 2A (ARCND2A) are distinct rare genetic disorders, each with characteristic clinical features. The simultaneous occurrence of these two syndromes is exceptionally rare and poses significant diagnostic challenges, especially in pediatric patients with complex phenotypes. Case Presentation: We report a 3-year-old Turkish girl who presented with multiple café-au-lait macules and dysmorphic facial features. Initial single-gene sequencing revealed a variant in the NF1 gene; however, the presence of severe craniofacial anomalies prompted further investigation. Clinical exome sequencing identified a likely pathogenic PLCB4 variant, establishing a dual molecular diagnosis of NF1 and ARCND2A. Comprehensive radiological assessment, including brain and orbital MRI with temporal bone CT, and maxillo-mandibular computed cone beam tomography (CBCT), revealed both craniofacial anomalies and central nervous system lesions consistent with ARCND2A and NF1. Notable findings included dehiscence in the left superior semicircular canal, mandibular and left sphenoid wing hypoplasia, as well as NF1-related hamartomatous lesions and optic pathway involvement. Discussion: The coexistence of NF1 and ARCND2A in a single pediatric patient complicates the clinical picture due to overlapping and atypical features. This dual diagnosis highlights the importance of considering multiple genetic etiologies when clinical findings cannot be fully explained by a single disorder. Conclusion: This case underscores the critical role of comprehensive genomic and radiological evaluation in children with unexplained or complex presentations. Recognizing the potential for multilocus genetic diagnoses is essential for accurate diagnosis, management, and genetic counseling.

2 February 2026 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
PDF file
ASAbdullah Sezer
Abdullah Sezer
FYFatma Zehra Yalçın
Fatma Zehra Yalçın
AKAbdulkerim Kolkiran
Abdulkerim Kolkiran
SÇSemra Çağlar Çetinkaya
Semra Çağlar Çetinkaya
Objectives: Meier–Gorlin syndrome (MGORS) is a rare primordial dwarfism characterized by microtia, patellar hypoplasia/aplasia, and short stature. Additional features may include skeletal, respiratory, urogenital, and endocrine abnormalities. 13 genes have been implicated, with DONSON , essential for replication fork stability and intra–S phase checkpoint activation, being the most recently identified. Only six patients with DONSON -related MGORS have been reported. This study expands the phenotype by presenting long-term follow-up and prenatal data in two affected siblings. Case presentation: The index patient, a 10-year-old male, had short stature, microcephaly, microtia, craniofacial features, hearing loss, patellar aplasia, and genitourinary anomalies. Despite an early growth delay, his height progressively improved without intervention. Whole-exome sequencing revealed a homozygous pathogenic c.631C>T p.(Arg211Cys) variant in DONSON (NM_017613.3). Following genetic counseling, the family declined prenatal testing in a subsequent pregnancy complicated by intrauterine growth restriction. The newborn female sibling carried the same variant and displayed DONSON -related MGORS features, including the first reported case of thumb aplasia. Additional findings in the family included renal hypoplasia, 2–4 toe syndactyly, and hypospadias. Conclusions: This is the third report of DONSON c.631C>T p.(Arg211Cys) in Turkish patients. While the recurrence in the same population suggests a founder effect, haplotype–based analysis is required. Thumb aplasia expands the known phenotype of DONSON -related MGORS, and the observed moderate course of growth retardation offers prognostic value. These findings highlight the importance of including DONSON in MGORS gene panels, considering population-specific variants, and systematically documenting rare phenotypic features to improve diagnosis, follow-up, and genetic counseling.